Journal of the Formosan Medical Association
Volume 108, Issue 12 , Pages 921-928 , December 2009

Hyperuricemia Associated With Rapid Renal Function Decline in Elderly Taiwanese Subjects

  • Chung-Jen Yen

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Chung-Jen Yen, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Chung-Shan South Road, Taipei 10006, Taiwan
    • Chung-Jen Yen and Chih-Kang Chiang contributed equally to this work.
  • ,
  • Chih-Kang Chiang

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei, Taiwan
    • Chung-Jen Yen and Chih-Kang Chiang contributed equally to this work.
  • ,
  • Li-Chun Ho

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • Division of Nephrology, Department of Internal Medicine, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan
  • ,
  • Sandy Huey-Jen Hsu

      Affiliations

    • Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Kuan-Yu Hung

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Kwan-Dun Wu

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Tun-Jun Tsai

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Received 17 February 2009 ,Revised 18 March 2009 ,Accepted 1 May 2009.

References 

  1. Reungjui S , Roncal CA , Mu W , et al.   Thiazide diuretics exacerbate fructose-induced metabolic syndrome . J Am Soc Nephrol . 2007;18:2724–2731
  2. Kang DH , Han L , Ouyang X , et al.   Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter . Am J Nephrol . 2005;25:425–433
  3. Kang DH , Park SK , Lee IK , et al.   Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells . J Am Soc Nephrol . 2005;16:3553–3562
  4. Kanellis J , Watanabe S , Li JH , et al.   Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 . Hypertension . 2003;41:1287–1293
  5. Ford ES , Li C , Cook S , et al.   Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents . Circulation . 2007;115:2526–2532
  6. Iseki K , Ikemiya Y , Inoue T , et al.   Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort . Am J Kidney Dis . 2004;44:642–650
  7. Iseki K , Oshiro S , Tozawa M , et al.   Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects . Hypertens Res . 2001;24:691–697
  8. Mazzali M , Kim YG , Suga S , et al.   Hyperuricemia exacerbates chronic cyclosporine nephropathy . Transplantation . 2001;71:900–905
  9. Myllymaki J , Honkanen T , Syrjanen J , et al.   Uric acid correlates with the severity of histopathological parameters in IgA nephropathy . Nephrol Dial Transplant . 2005;20:89–95
  10. Kang DH , Nakagawa T , Feng L , et al.   A role for uric acid in the progression of renal disease . J Am Soc Nephrol . 2002;13:2888–2897
  11. Ohno I , Hosoya T , Gomi H , et al.   Serum uric acid and renal prognosis in patients with IgA nephropathy . Nephron . 2001;87:333–339
  12. Fessel WJ . Renal outcomes of gout and hyperuricemia . Am J Med . 1979;67:74–82
  13. Yu TF , Berger L . Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease . Am J Med . 1982;72:95–100
  14. Siu YP , Leung KT , Tong MK , et al.   Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level . Am J Kidney Dis . 2006;47:51–59
  15. Obermayr RP , Temml C , Gutjahr G , et al.   Elevated uric acid increases the risk for kidney disease . J Am Soc Nephrol . 2008;19:2407–2413
  16. Chonchol M , Shlipak MG , Katz R , et al.   Relationship of uric acid with progression of kidney disease . Am J Kidney Dis . 2007;50:239–247
  17. Weiner DE , Tighiouart H , Elsayed EF , et al.   Uric acid and incident kidney disease in the community . J Am Soc Nephrol . 2008;19:1204–1211
  18. Levey AS , Coresh J , Balk E , et al.   National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification . Ann Intern Med . 2003;139:137–147
  19. National Kidney Foundation  . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification . Am J Kidney Dis . 2002;39(2 Suppl 1):S1–S266
  20. Fried L , Solomon C , Shlipak M , et al.   Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals . J Am Soc Nephrol . 2004;15:3184–3191
  21. Klein R , Klein BE , Moss SE , et al.   The 10-year incidence of renal insufficiency in people with type 1 diabetes . Diabetes Care . 1999;22:743–751
  22. Rao GN , Corson MA , Berk BC . Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression . J Biol Chem . 1991;266:8604–8608
  23. Umekawa T , Chegini N , Khan SR . Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals . Nephrol Dial Transplant . 2003;18:664–669
  24. Mazzali M , Kanellis J , Han L , et al.   Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism . Am J Physiol Renal Physiol . 2002;282:F991–F997
  25. Mazzali M , Hughes J , Kim YG , et al.   Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism . Hypertension . 2001;38:1101–1106
  26. Nakagawa T , Mazzali M , Kang DH , et al.   Hyperuricemia causes glomerular hypertrophy in the rat . Am J Nephrol . 2003;23:2–7
  27. Chien KL , Hsu HC , Sung FC , et al.   Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort Study . Atherosclerosis . 2005;183:147–155
  28. Johnson RJ , Kivlighn SD , Kim YG , et al.   Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease . Am J Kidney Dis . 1999;33:225–234
  29. Jankowska EA , Ponikowska B , Majda J , et al.   Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure . Int J Cardiol . 2007;115:151–155
  30. Culleton BF , Larson MG , Kannel WB , et al.   Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study . Ann Intern Med . 1999;131:7–13
  31. Nagahama K , Inoue T , Iseki K , et al.   Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan . Hypertens Res . 2004;27:835–841
  32. Syrjanen J , Mustonen J , Pasternack A . Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy . Nephrol Dial Transplant . 2000;15:34–42

PII: S0929-6646(10)60004-6

doi: 10.1016/S0929-6646(10)60004-6

Journal of the Formosan Medical Association
Volume 108, Issue 12 , Pages 921-928 , December 2009